For heart failure patients, risk of in-hospital death has decreased; readmission rate has increased

Jun 01, 2010

An analysis of Medicare data from 1993 through 2006 for older patients hospitalized for heart failure indicates that along with a decrease in hospital length of stay, the rate of in-hospital and 30-day mortality has decreased, while the rate of hospital readmission and discharge to skilled nursing facilities has increased, according to a study in the June 2 issue of JAMA.

"During the last decade, the most prominent change in the acute care of patients with (HF) was a decreasing length of stay in hospi­tals," the authors write. Whether this decrease may be associated with changes in outcomes is not known.

Hector Bueno, M.D., Ph.D., of Hospital General Universitario Gregorio Maranon, Madrid, Spain, and colleagues conducted a study to determine if during a period of de­creasing length of hospital stay for heart failure, there were changes in short-term mortality, readmission and discharge to skilled nurs­ing facilities, using data from . The analysis included 6,955,461 Medi­care fee-for-service hospitalizations for heart failure between 1993 and 2006, with a 30-day follow-up.

Between 1993 and 2006, average length of stay decreased from 8.8 days to 6.3 days. The researchers found that in-hospital mortality decreased from 8.5 percent in 1993 to 4.3 percent in 2006, a 49 percent relative reduction; and the 30-day mortality rate decreased by 2.1 percent, from 12.8 percent to 10.7 percent. There was an increase in postdischarge mortality (from dis­charge to the 30th day after admis­sion), from 4.3 percent in 1993 to 6.4 percent in 2006.

In 1993, a total of 74.0 percent of HF patients were dis­charged to home or under home care service, compared to 66.9 percent of patients in 2006. Thirteen percent of patients were discharged to skilled nursing facilities in 1993; in 2006, that figure was 19.9 percent, a relative increase of 53 percent. Thirty-day readmission rates increased from 17.2 percent to 20.1 percent.

"The most striking finding is that the period was associated with an in­crease in 30-day readmission rate. Al­though we cannot demonstrate that the shortened hospital stay caused these changes, it is certainly plausible that the effort to discharge patients quickly has led to transfers to nonacute institu­tional settings and occasionally sent pa­tients out of the hospital before they were fully treated," the authors write.

The researchers add that from the patient perspective, it is not clear that care in 2006 was markedly better than it was in 1993. "The outcome of pa­tients hospitalized for HF measured by short-term mortality has improved, which may be a result of better quality of care. However, because length of stay has substantially decreased, improve­ment is less than what might be suggested by in-hospital . In contrast with that improvement, rates of readmission and discharge to skilled nursing facilities have increased, sug­gesting that patient outcomes, al­though better, have not improved in all areas."

"The current model of care for older patients with HF in the United States may benefit from more attention to the care and outcomes in the early transi­tion period after hospital discharge and routine surveillance of how changes in practice affect patient outcomes."

Explore further: Hormonal therapy for transsexualism safe and effective

More information: JAMA. 2010;303[21]:2141-2147

add to favorites email to friend print save as pdf

Related Stories

Lower-cost hospital care is not always lower in quality

Feb 22, 2010

The costs that hospitals incur in treating patients vary widely and do not appear to be strongly associated either with the quality of care patients receive or their risk of dying within 30 days, according to a report in ...

New tool to predict early death or hospital readmission

Mar 01, 2010

A new tool can help physicians predict the likelihood of death or readmission to hospital for patients within 30 days of discharge from hospital, according to a new study in CMAJ (Canadian Medical Association Journal).

Recommended for you

Hormonal therapy for transsexualism safe and effective

13 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

16 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

3D printing tiny batteries

(Phys.org) —3D printing can now be used to print lithium-ion microbatteries the size of a grain of sand. The printed microbatteries could supply electricity to tiny devices in fields from medicine to communications, ...